THE IMPACT OF PRETRANSPLANTATION HEPATITIS-C INFECTION ON THE OUTCOMEOF RENAL-TRANSPLANTATION

Citation
Bjg. Periera et al., THE IMPACT OF PRETRANSPLANTATION HEPATITIS-C INFECTION ON THE OUTCOMEOF RENAL-TRANSPLANTATION, Transplantation, 60(8), 1995, pp. 799-805
Citations number
54
Categorie Soggetti
Immunology,Surgery,Transplantation
Journal title
ISSN journal
00411337
Volume
60
Issue
8
Year of publication
1995
Pages
799 - 805
Database
ISI
SICI code
0041-1337(1995)60:8<799:TIOPHI>2.0.ZU;2-W
Abstract
Controversy exists regarding the impact of pretransplantation HCV infe ction on the outcome of renal transplantation. We compared the prevale nce of posttransplantation liver disease and graft and patient surviva l among kidney transplant recipients with and without anti-HCV at the time of transplantation. Pretransplantation sera from 103 randomly sel ected recipients of kidneys from anti-HCV-negative donors were tested for anti-HCV using a second generation ELISA. Twenty-three (22%) were positive for anti-HCV and 80 (78%) were negative. Anti-HCV-positive re cipients had a longer time on dialysis (P=0.003) and had a higher numb er of previous transplants (P=0.01). Further, 61% of anti-HCV-positive patients had a history of Liver disease compared with 13% of anti-HCV -negative patients (P<0.001). HCV RNA was detected in the pretransplan tation serum in 61% of anti-HCV positive recipients compared with 5% o f anti-HCV-negative recipients (P<0.001). Clinical follow-up on both a nti-HCV-positive and -negative patients was obtained until December, 1 993. Median posttransplantation follow-up among recipients with anti-H CV prior to transplantation (45 months) was shorter (P=0.05) than that for recipients without anti-HCV (66 months). For recipients with anti -HCV prior to transplantation, the relative risk of posttransplantatio n liver disease was 5.0 (95% confidence intervals of 2.4 to 10.5); the relative risk of graft loss was 1.3 (95% confidence intervals of 0.6 to 2.6); the relative risk of death was 3.3 (95% confidence intervals of 1.4 to 7.9), and the relative risk of death due to sepsis was 9.9 ( 95% confidence intervals of 2.6 to 38.3). The results of this study de monstrate that pretransplantation HCV infection is associated with an increased risk of liver disease and death after renal transplantation. These results raise the question of whether anti-HCV-positive patient s on dialysis should be offered renal transplantation as opposed to co ntinuing dialysis.